Mersana Therapeutics (MRSN) News Today $7.75 -0.36 (-4.44%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.76 +0.01 (+0.19%) As of 08/22/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRSN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Recommendation of "Buy" from Analysts1 hour ago | americanbankingnews.comQ3 Earnings Estimate for MRSN Issued By Leerink PartnrsAugust 19, 2025 | americanbankingnews.comQ3 EPS Forecast for Mersana Therapeutics Lifted by AnalystAugust 18, 2025 | americanbankingnews.comResearch Analysts Offer Predictions for MRSN Q3 EarningsAugust 17, 2025 | americanbankingnews.comMersana Therapeutics (NASDAQ:MRSN) Price Target Cut to $36.00 by Analysts at Truist FinancialAugust 16, 2025 | americanbankingnews.comMersana Therapeutics price target adjusted to $36 at Truist after reverse splitAugust 14, 2025 | msn.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | insidermonkey.comMersana Therapeutics Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | msn.comMersana Therapeutics reports Q2 EPS ($4.87), consensus ($4.25)August 13, 2025 | msn.comMersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comMersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial ResultsAugust 13, 2025 | finanznachrichten.deMersana Misses Fiscal Q2 Revenue TargetAugust 13, 2025 | theglobeandmail.comMersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial ResultsAugust 13, 2025 | finance.yahoo.comMersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial ResultsAugust 13, 2025 | globenewswire.comMersana Therapeutics Q2 2025 Earnings PreviewAugust 12, 2025 | msn.comA Look at Mersana Therapeutics's Upcoming Earnings ReportAugust 12, 2025 | benzinga.comEarnings To Watch: Mersana Therapeutics Inc (MRSN) Reports Q2 2025 ResultAugust 12, 2025 | finance.yahoo.comMersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025August 6, 2025 | globenewswire.comMersana Therapeutics (NASDAQ:MRSN) Stock Price Down 5.3% - Here's What HappenedJuly 29, 2025 | marketbeat.comMersana Therapeutics trading halted, news pendingJuly 26, 2025 | msn.comMersana Therapeutics Presents Positive Phase 1 Data for Cancer Drug Emi-Le at ASCO 2025July 25, 2025 | msn.comMersana Therapeutics Announces 1-for-25 Reverse Stock SplitJuly 24, 2025 | globenewswire.comMersana Therapeutics Settles Debt with Oxford FinanceJuly 3, 2025 | tipranks.comMersana Therapeutics Inc (MRSN) - Investing.comJuly 2, 2025 | investing.comMersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual MeetingJune 2, 2025 | globenewswire.comMersana Therapeutics to Present at Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comQ1 2025 Mersana Therapeutics Inc Earnings CallMay 16, 2025 | uk.finance.yahoo.comMersana Therapeutics Inc (MRSN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...May 16, 2025 | finance.yahoo.comMersana extends cash runway into mid-2026 as restructuring narrows focus to breast cancerMay 15, 2025 | msn.comCORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | finance.yahoo.comCORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comMersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | finance.yahoo.comMersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Mersana Therapeutics (MRSN) and IQVIA Holdings (IQV)May 9, 2025 | theglobeandmail.comMersana Therapeutics announces strategic cutbacks amid economic pressuresMay 7, 2025 | investing.comMersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast CancerMay 6, 2025 | globenewswire.com4,250,000 Shares in Mersana Therapeutics, Inc. (NASDAQ:MRSN) Purchased by Novo Holdings A SMay 3, 2025 | marketbeat.comMersana Therapeutics (MRSN) Expected to Announce Earnings on ThursdayMay 3, 2025 | marketbeat.comMersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual MeetingApril 23, 2025 | globenewswire.comMersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual CongressApril 1, 2025 | globenewswire.comMersana at Leerink Global Healthcare Conference: Strategic ADC InsightsMarch 13, 2025 | investing.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarch 13, 2025 | marketbeat.comQ1 EPS Estimates for Mersana Therapeutics Cut by WedbushMarch 7, 2025 | marketbeat.comWhat is William Blair's Estimate for MRSN Q1 Earnings?March 7, 2025 | marketbeat.comEarnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their EstimatesMarch 6, 2025 | finance.yahoo.comWhat is Leerink Partnrs' Forecast for MRSN FY2025 Earnings?March 6, 2025 | marketbeat.comIndustry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue ForecastsMarch 5, 2025 | finance.yahoo.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | insidermonkey.comAnalysts Set Expectations for MRSN Q1 EarningsMarch 4, 2025 | marketbeat.com Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address MRSN Media Mentions By Week MRSN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRSN News Sentiment▼0.180.69▲Average Medical News Sentiment MRSN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRSN Articles This Week▼102▲MRSN Articles Average Week Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IOBT News Today MOLN News Today IMRX News Today GNLX News Today HURA News Today CTOR News Today CLYM News Today ALTS News Today ACOG News Today IKT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRSN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mersana Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access